patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: ANY TARGETS

This is going to be, IMHO, a very volatile stock until the FDA

in response to by
posted on Mar 09, 2007 05:56AM

trials are completed. The fact that PLRS's tech has been approved for use in South Africa is, in my view, a hint at the future. I view this as a very long term accumulate and hold and particularly at this level. Very little investment could result in huge gain with only normal penny stock risk. I intend to continue to accumulate as funds allow. GLTAL

Kirk

Share
New Message
Please login to post a reply